NilotinibIn the First-Line Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia in Chronic Phase

被引：0
|
作者：
Karly P. Garnock-Jones
机构：
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源：
Drugs | 2011年 / 71卷
关键词：
Imatinib; Chronic Myeloid Leukaemia; Nilotinib; Anagrelide; Major Molecular Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nilotinib is an effective first-line treatment for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (CML) in chronic phase. It is an aminopyrimidine-based, high-affinity inhibitor of the tyrosine kinase activity of BCR-ABL. It thus decreases ABL-associated cell proliferation and kinase autophosphorylation.
引用
收藏
页码：1579 / 1590
页数：11
相关论文
共 50 条
  • [21] Dasatinib for the treatment of Philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure
    Hochhaus, Andreas
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (18) : 3257 - 3264
  • [22] Exposure-Efficacy Analysis of Asciminib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
    Combes, Francois Pierre
    Li, Ying Fei
    Hoch, Matthias
    Lorenzo, Sebastien
    Ho, Yu-Yun
    Sy, Sherwin K. B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (05) : 1040 - 1050
  • [23] RETRACTION: Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Retraction of Vol 17, Pg 1851, 2016)
    Saydam, Guray
    Haznedaroglu, Ibrahim C.
    Kaynar, Leylagul
    Yavuz, Akif S.
    Ali, Ridvan
    Guvenc, Birol
    Akay, Olga M.
    Baslar, Zafer
    Ozbek, Ugur
    Sonmez, Mehmet
    Aydin, Demet
    Pehlivan, Mustafa
    Undar, Bulent
    Dagdas, Simten
    Ayyildiz, Orhan
    Akkaynak, Diyar Z.
    Akin, Gulnur
    Ilhan, Osman
    HEMATOLOGY, 2018, 23 (09) : 720 - 720
  • [24] Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
    R A Larson
    A Hochhaus
    T P Hughes
    R E Clark
    G Etienne
    D-W Kim
    I W Flinn
    M Kurokawa
    B Moiraghi
    R Yu
    R E Blakesley
    N J Gallagher
    G Saglio
    H M Kantarjian
    Leukemia, 2012, 26 : 2197 - 2203
  • [25] Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
    Larson, R. A.
    Hochhaus, A.
    Hughes, T. P.
    Clark, R. E.
    Etienne, G.
    Kim, D-W
    Flinn, I. W.
    Kurokawa, M.
    Moiraghi, B.
    Yu, R.
    Blakesley, R. E.
    Gallagher, N. J.
    Saglio, G.
    Kantarjian, H. M.
    LEUKEMIA, 2012, 26 (10) : 2197 - 2203
  • [26] Ponatinib in childhood Philadelphia chromosome-positive leukaemias: an international registry of childhood chronic myeloid leukaemia study
    Millot, Frederic
    Suttorp, Meinolf
    Versluys, Anne B.
    Kalwak, Krzysztof
    Nelken, Brigitte
    Ducassou, Stephane
    Bertrand, Yves
    Baruchel, Andre
    EUROPEAN JOURNAL OF CANCER, 2020, 136 : 107 - 112
  • [27] ASC4START and ASC4FIRST: Two Ongoing Phase 3 Trials Investigating Asciminib Monotherapy As First-Line Therapy Versus Tyrosine Kinase Inhibitors in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
    Hochhaus, Andreas
    Cortes, Jorge
    Takahashi, Naoto
    Larson, Richard A.
    Issa, Ghayas C.
    Bombaci, Felice
    Saussele, Susanne
    Mahon, Francois
    Bruemmendorf, Tim H.
    Kapoor, Shruti
    McCulloch, Tracey
    Schuld, Peter
    Hughes, Timothy P.
    BLOOD, 2023, 142
  • [28] PONATINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
    Narayanan, V.
    Pollyea, D. A.
    Gutman, J. A.
    Jimeno, A.
    DRUGS OF TODAY, 2013, 49 (04) : 261 - 269
  • [29] MOLECULAR DIAGNOSIS OF PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA
    ZACCARIA, A
    TASSINARI, A
    GUERRASIO, A
    ROSSO, C
    LOCOCO, F
    DIVERIO, D
    TESTONI, N
    CELSO, B
    BUZZI, M
    TURA, S
    SAGLIO, G
    HAEMATOLOGICA, 1991, 76 (03) : 183 - 187
  • [30] A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea
    Shin, Junghoon
    Koh, Youngil
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Kim, Dae-Young
    Lee, Kyoo-Hyung
    Kim, Hyeong-Joon
    Ahn, Jae-Sook
    Kim, Yeo-Kyeoung
    Park, Jinny
    Sohn, Sang-Kyun
    Moon, Joon Ho
    Lee, Yoo Jin
    Yoon, Seonghae
    Lee, Jeong-Ok
    Cheong, June-Won
    Ha Kim, Kyoung
    Kim, Sung-Hyun
    Kim, Hoon-Gu
    Kim, Hawk
    Nam, Seung-Hyun
    Do, Young Rok
    Park, Sang-Gon
    Park, Seong Kyu
    Bae, Sung Hwa
    Song, Hun Ho
    Shin, Dong-Yeop
    Oh, Doyeun
    Kim, Min Kyoung
    Jung, Chul Won
    Park, Seonyang
    Kim, Inho
    CANCER MEDICINE, 2018, 7 (05): : 1814 - 1823
12345